Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 8 | 2023 | 394 | 2.460 |
Why?
|
| Programmed Cell Death 1 Receptor | 4 | 2023 | 120 | 1.200 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2022 | 9 | 0.940 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1245 | 0.860 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2022 | 12 | 0.730 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 337 | 0.660 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 549 | 0.610 |
Why?
|
| Antigens, CD | 1 | 2019 | 421 | 0.580 |
Why?
|
| Transcriptome | 3 | 2022 | 936 | 0.570 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 1697 | 0.550 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2022 | 109 | 0.530 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1604 | 0.430 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2022 | 196 | 0.370 |
Why?
|
| Neoplasms | 2 | 2022 | 2794 | 0.350 |
Why?
|
| Head and Neck Neoplasms | 2 | 2025 | 497 | 0.300 |
Why?
|
| Smoke | 1 | 2025 | 61 | 0.230 |
Why?
|
| Immunity | 1 | 2025 | 191 | 0.220 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 2 | 2023 | 13 | 0.220 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2019 | 14 | 0.210 |
Why?
|
| Clone Cells | 1 | 2022 | 168 | 0.190 |
Why?
|
| Interleukin-2 | 1 | 2022 | 225 | 0.190 |
Why?
|
| Immunotherapy | 2 | 2023 | 662 | 0.180 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Virus Diseases | 1 | 2023 | 279 | 0.170 |
Why?
|
| Papillomaviridae | 1 | 2020 | 137 | 0.170 |
Why?
|
| Granzymes | 1 | 2019 | 37 | 0.170 |
Why?
|
| Oxidative Stress | 1 | 2025 | 813 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2023 | 1932 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 481 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 525 | 0.140 |
Why?
|
| Stem Cells | 1 | 2019 | 701 | 0.120 |
Why?
|
| Humans | 9 | 2025 | 124311 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 4425 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 1149 | 0.110 |
Why?
|
| Mice | 5 | 2025 | 17740 | 0.110 |
Why?
|
| Brain | 1 | 2023 | 3005 | 0.090 |
Why?
|
| Biomarkers | 1 | 2019 | 2976 | 0.090 |
Why?
|
| Animals | 5 | 2025 | 34154 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2025 | 114 | 0.060 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2022 | 13 | 0.050 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2022 | 6 | 0.050 |
Why?
|
| CD28 Antigens | 1 | 2022 | 78 | 0.050 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 44 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2022 | 121 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 372 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2022 | 185 | 0.050 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 18 | 0.050 |
Why?
|
| Germinal Center | 1 | 2020 | 38 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2020 | 54 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 426 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 69 | 0.040 |
Why?
|
| Cell Separation | 1 | 2020 | 229 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2019 | 103 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2022 | 334 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 57 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2019 | 61 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 1154 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 273 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3342 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 771 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 1900 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 953 | 0.040 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 288 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 656 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 673 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1015 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1701 | 0.030 |
Why?
|
| Male | 1 | 2019 | 60976 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2038 | 0.030 |
Why?
|
| Female | 1 | 2019 | 66248 | 0.030 |
Why?
|
| Phenotype | 1 | 2022 | 4257 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 4355 | 0.030 |
Why?
|